Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study.
European HTN Risk Index
European IR Risk Index
hypertension
screening
type 2 diabetes
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
30 Mar 2020
30 Mar 2020
Historique:
received:
03
03
2020
revised:
22
03
2020
accepted:
26
03
2020
entrez:
3
4
2020
pubmed:
3
4
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Early identification of type 2 diabetes mellitus (T2DM) and hypertension (HTN) risk may improve prevention and promote public health. Implementation of self-reported scores for risk assessment provides an alternative cost-effective tool. The study aimed to develop and validate two easy-to-apply screening tools identifying high-risk individuals for insulin resistance (IR) and HTN in a European cohort. Sociodemographic, lifestyle, anthropometric and clinical data obtained from 1581 and 1350 adults (baseline data from the Feel4Diabetes-study) were used for the European IR and the European HTN risk assessment index respectively. Body mass index, waist circumference, sex, age, breakfast consumption, alcohol, legumes and sugary drinks intake, physical activity and sedentary behavior were significantly correlated with Homeostatic Model Assessment of IR (HOMA-IR) and/or HTN and incorporated in the two models. For the IR index, the Area Under the Curve (AUC), sensitivity and specificity for identifying individuals above the 75th and 95th of HOMA-IR percentiles were 0.768 (95%CI: 0.721-0.815), 0.720 and 0.691 and 0.828 (95%CI: 0.766-0.890), 0.696 and 0.778 respectively. For the HTN index, the AUC, sensitivity and specificity were 0.778 (95%CI: 0.680-0.876), 0.667 and 0.797. The developed risk assessment tools are easy-to-apply, valid, and low-cost, identifying European adults at high risk for developing T2DM or having HTN.
Identifiants
pubmed: 32235566
pii: nu12040960
doi: 10.3390/nu12040960
pmc: PMC7230581
pii:
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Union's Horizon 2020
ID : 643708
Références
Eur J Clin Invest. 2007 Jul;37(7):535-43
pubmed: 17576204
Hypertension. 2006 Mar;47(3):403-9
pubmed: 16432042
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Public Health Nutr. 2018 Dec;21(17):3281-3290
pubmed: 30207513
Diabetes Care. 2010 Jul;33(7):1695-7
pubmed: 20587733
Diabetes Care. 2003 May;26(5):1338-43
pubmed: 12716785
Clin Cornerstone. 2007;8 Suppl 7:S7-18
pubmed: 18159645
World J Diabetes. 2015 Dec 10;6(17):1337-44
pubmed: 26675051
Diabetes Metab. 2011 Apr;37(2):144-51
pubmed: 21144787
J Clin Hypertens (Greenwich). 2015 Oct;17(10):812-8
pubmed: 25644577
Can J Diabetes. 2018 Apr;42 Suppl 1:S16-S19
pubmed: 29650090
BMC Cardiovasc Disord. 2014 Nov 11;14:158
pubmed: 25387527
Adv Nutr. 2015 Nov 13;6(6):665-73
pubmed: 26567192
Diabetes Care. 2005 Aug;28(8):2013-8
pubmed: 16043747
BMC Med. 2013 Feb 21;11:45
pubmed: 23438147
J Clin Hypertens (Greenwich). 2010 Oct;12(10):800-8
pubmed: 21029343
Chronic Dis Inj Can. 2011 Dec;32(1):19-31
pubmed: 22153173
Am J Epidemiol. 2006 Apr 1;163(7):670-5
pubmed: 16410346
Diabetes Res Clin Pract. 2007 May;76 Suppl 1:S3-12
pubmed: 17343954
Ann Intern Med. 2015 Nov 17;163(10):778-86
pubmed: 26458123
Diabet Med. 2010 Aug;27(8):887-95
pubmed: 20653746
Diabetologia. 2006 Feb;49(2):289-97
pubmed: 16391903
Eur Heart J. 2013 Jul;34(28):2108-9
pubmed: 24040671
Diabetes Res Clin Pract. 2011 Apr;92(1):46-52
pubmed: 21242013
Med J Aust. 2010 Feb 15;192(4):197-202
pubmed: 20170456
Diabetes Care. 2002 Jul;25(7):1177-84
pubmed: 12087016
Diabetes. 2006 Apr;55(4):1074-9
pubmed: 16567531
Lancet. 2019 Aug 24;394(10199):639-651
pubmed: 31327564
BMJ. 2017 Nov 20;359:j5019
pubmed: 29158232
Diabetes. 2005 Nov;54(11):3252-7
pubmed: 16249452
Ann Intern Med. 2005 Mar 1;142(5):323-32
pubmed: 15738451
Diabetes Care. 2003 Mar;26(3):725-31
pubmed: 12610029
Diabetes Care. 2005 May;28(5):1187-94
pubmed: 15855587
Hypertension. 2019 May;73(5):e35-e66
pubmed: 30827125
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Am J Hypertens. 2015 Nov;28(11):1316-24
pubmed: 25801901
Diabetes Metab. 2009 Dec;35(6):458-62
pubmed: 19879790
Ann Intern Med. 2008 Jan 15;148(2):102-10
pubmed: 18195335
Diabetes Res Clin Pract. 2019 Apr;150:99-110
pubmed: 30796939
Nat Med. 2017 Jul 11;23(7):804-814
pubmed: 28697184
G Ital Cardiol (Rome). 2018 Nov;19(11 Suppl 1):3S-73S
pubmed: 30520455
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
PLoS One. 2014 May 22;9(5):e97865
pubmed: 24852786
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Hypertension. 1996 Aug;28(2):256-64
pubmed: 8707391
Am J Lifestyle Med. 2015 Nov 24;12(1):4-20
pubmed: 30202378